The Expression of CD40/CD40L in MM Patients and Its Significance to the Prognosis of MM Patients

Zeng-Qiang YAN; Hong-Mei MA; Jian-Xin REN; Zhi-Jun XIE; Xiao-Lei LI.
Journal of Experimental Hematology ; (6): 167-171, 2021.
Artículo en Zh | WPRIM | ID: wpr-880048

Documentos relacionados

  1. CD40-CD154: A perspective from type 2 immunity.
  2. [The Expression of CD40/CD40L in MM Patients and Its Significance to the Prognosis of MM Patients].
  3. CD40-CD40L in Neurological Disease.
  4. Initial evidence that blockade of the CD40/CD154 costimulation pathway alone is sufficient as maintenance therapy in xenotransplantation.
  5. Importance of CD40/CD40 dyad in the course of infection with Trypanosoma cruzi: Impact of its inhibition.
  6. Crystal structures of human CD40 in complex with monoclonal antibodies dacetuzumab and bleselumab.
  7. [Association between CD40-CD40L system and obesity in children].
  8. Advanced computational analysis of CD40LG variants in atypical X-linked hyper-IgM syndrome.
  9. CD40 stimulation via CD40 ligand enhances adenovirus-mediated tumour immunogenicity including 'find-me', 'eat-me', and 'kill-me' signalling.
  10. Preclinical Immunopharmacologic Assessment of KPL-404, a Novel, Humanized, Non-Depleting Antagonistic Anti-CD40 Monoclonal Antibody.